A truncated form of IKKa is responsible for specific nuclear IKK activity in colorectal cancer
Author
Publication date
2012-10-25ISSN
2211-1247
Abstract
Nuclear IKKα regulates gene transcription by phosphorylating specific substrates and has been linked to cancer progression and metastasis. However, the mechanistic connection between tumorigenesis and IKKα activity remains poorly understood. We have now analyzed 288 human colorectal cancer samples and found a significant association between the presence of nuclear IKK and malignancy. Importantly, the nucleus of tumor cells contains an active IKKα isoform with a predicted molecular weight of 45 kDa (p45-IKKα) that includes the kinase domain but lacks several regulatory regions. Active nuclear p45-IKKα forms a complex with nonactive IKKα and NEMO that mediates phosphorylation of SMRT and histone H3. Proteolytic cleavage of FL-IKKα into p45-IKKα is required for preventing the apoptosis of CRC cells in vitro and sustaining tumor growth in vivo. Our findings identify a potentially druggable target for treating patients with advance refractory CRC.
Document Type
Article
Document version
Published version
Language
English
Subject (CDU)
61 - Medical sciences
616 - Pathology. Clinical medicine
Keywords
Pages
15
Publisher
Elsevier
Collection
2; 4
Is part of
Cell Reports
Recommended citation
Margalef, Pol; Fernández-Majada, Vanessa; Villanueva, Alberto [et al.]. A truncated form of IKKa is responsible for specific nuclear IKK activity in colorectal cancer. Cell Reports, 2012, 2(4), p. 840-854. Disponible en: <https://www.sciencedirect.com/science/article/pii/S2211124712002689?via%3Dihub>. Fecha de acceso: 28 oct. 2020. DOI: 10.1016/j.celrep.2012.08.028.
Note
We thank M. Karin and G. Capella` for DNA constructs and reagents, and Julia Ingles-Esteve and Berta Alsina for critical reading of the manuscript. P.M. is a recipient of a FPU fellowship (AP2009-2892) and M.C.M. is funded by the ‘‘Sara Borrell’’ Program from MICIN (CD09/00421). This work was supported by Fondo de Investigaciones Sanitarias (PI07/0778 and PI10/01128), AGAUR (2009SGR23), Fondos Feder RD06/0020/0098 and RD09/0076/00036, and Xarxa de Bancs de tumors sponsored by Pla Director d’Oncologia de Catalunya (XBTC). M.W.M. was supported by funds from the NIH/NCI R01 CA104397.
This item appears in the following Collection(s)
- Ciències de la Salut [980]
Rights
© 2012 The Authors. Published by Elsevier Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License (CC-BY-NC-ND; http://creativecommons.org/licenses/by-nc-nd/3.0/ legalcode)
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/3.0/


